Financials
- Market Capitalization 43.12 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.59
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4295 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.13 USD | +1.43% | -0.93% | 0.00% | -46.48% | 44.81 M USD | ||
| 4301 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.16 USD | -0.85% | -4.92% | -2.52% | -19.44% | 43.82 M USD | ||
| 4330 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.79 USD | -3.24% | -8.67% | -7.73% | -81.43% | 40.60 M USD | ||
| 4338 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.22 USD | +2.13% | -17.18% | +44.99% | -36.47% | 38.79 M USD |